CD27 and rheumatoid arthritis: Poor clinical response to RTX in both RA and SLE is associated with a higher number and/or frequency of CD27+ memory cells [1, 2, 5] and also with DN B cells in RA [5], suggesting that resistance to depletion of different B cell subpopulations is clinically relevant [6].